VivoSim Labs, Inc. (VIVS)
$0.18+0.00%Close
SELLCRISIS · day 19
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $462,353
- Beta
- 1.49
- P/E (TTM)
- -0.03
- Short % float
- 30.91%
- Days to cover
- 1.0
- SI change
- +25.4%
- 1W
- -10.00%
- 1M
- -40.00%
- vs SPY 1W
- -11.16%
- vs SPY 1M
- -42.99%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on VIVS?
- LOPJLB’s latest quantitative signal on VivoSim Labs, Inc. (VIVS) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is VIVS in?
- VivoSim Labs, Inc. (VIVS) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does VivoSim Labs, Inc. (VIVS) do?
- VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action eluci…